Open AccessMP18-09 INFLUENCE OF GA-PSMA PET/CT ON CLINICAL DECISION MAKING IN THE TREATMENT OF PATIENTS WITH PROSTATE CANCER.
Author(s) -
Carlos Ferreira,
Liliana Violante,
Rui Freitas,
Isaac Braga,
Víctor Silva,
Sanches Magalhães,
Francisco S. N. Lobo,
António Morais,
Hugo Duarte,
Jorge Oliveira
Publication year - 2017
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2017.02.619
Subject(s) - medicine , prostate cancer , stage (stratigraphy) , positron emission tomography , cancer , prostate , radiology , gynecology , paleontology , biology
Accuracy for mpMR was 52.94% and 70.79% for readers M1 and M2, respectively. Overall, fluciclovine PET had higher sensitivity and specificity compared to mpMR (Figure 1b). Inter-reader agreement for fluciclovine PET was 91.6% in the prostate and 87.5% for extraprostatic disease detection. For mpMRI, inter-reader agreement was 37.5% and 75% respectively for prostate and extraprostatic disease detection. CONCLUSIONS: Although fluciclovine PET-CT had higher sensitivity in the prostate, MRI had higher specificity for disease detection. However for extraprostatic disease, fluciclovine had higher sensitivity and specificity. Inter-reader agreement was better with fluciclovine PET-CT compared with mpMR.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom